Nektar Therapeutics (NKTR)

NASDAQ
3.46
0.00(0.00%)
  • Volume:
    2,241,349
  • Day's Range:
    3.42 - 3.60
  • 52 wk Range:
    3.30 - 19.37

NKTR Overview

Prev. Close
3.46
Day's Range
3.42-3.6
Revenue
103.08M
Open
3.47
52 wk Range
3.3-19.37
EPS
-2.67
Volume
2,241,349
Market Cap
648.23M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
4,228,874
P/E Ratio
-
Beta
1.38
1-Year Change
-80.31%
Shares Outstanding
186,274,156
Next Earnings Date
Aug 11, 2022
What is your sentiment on Nektar?
or
Market is currently closed. Voting is open during market hours.

Nektar Therapeutics News

Nektar Therapeutics Analysis

Nektar Therapeutics Company Profile

Nektar Therapeutics Company Profile

Employees
740

Nektar Therapeutics is a research-based biopharmaceutical company, which is focused on discovering and developing medicines in areas of unmet medical need. The Company's research and development pipeline of new investigational drugs includes potential therapies for oncology, immunology and virology. In oncology, it is studying several immuno-oncology (I-O) drug candidates, including bempegaldesleukin, NKTR-255 and NKTR-262. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In autoimmune disorders, its IL-2 T-regulatory cell stimulator NKTR-358 is being clinically studied in systemic lupus erythematosus, ulcerative colitis, psoriasis and atopic dermatitis. Its programs in virology area include studying bempegaldesleukin in treating individuals affected with COVID-19, and a preclinical research collaboration with Gilead Sciences Inc. (Gilead) to test the combination of NKTR-255.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellBuyStrong SellStrong Sell
SummaryStrong SellStrong SellNeutralStrong SellStrong Sell
  • Punished too hard, will recover quickly and a 6 dollar will be there before friday IMO. Bullish on this one
    1
    • Investors will die, if this goes daily down
      0
      • Hold forever
        0
        • They better do what they're supposed to, reach 31 :D
          0
          • ok
            0
          • hi
            0
        • That's a crappy stock bro. Don't be pushing that garbage in here!
          1
          • AMC and Koss
            3
            • why this gone down so much today any idea?
              0
              • TUSK double the price very soon..Very low volume.. Easy to jump.. Don't miss it.. Good luck guys..
                0
                • k
                  0
              • PDUFA on the 14th. probably reason for run up
                1
                • Why going up?
                  1